schliessen

Filtern

 

Bibliotheken

Cover Image

Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions

ABSTRACT Objective: To evaluate physicians' attitudes and adherence to the use of risk scores in the primary prevention of cardiovascular disease (CVD). Design and methods: A cross-sectional survey of 2056 physicians involved in the primary prevention of CVD. Participants included cardiologists (47%... Full description

Journal Title: Current medical research and opinion 2009, Vol.25 (5), p.1171-1178
Main Author: Sposito, Andrei C
Other Authors: Ramires, Jose A. F , Jukema, J. Wouter , Molina, Juan Carlos , Silva, Pedro Marques da , Ghadanfar, Mathieu M , Wilson, Peter W. F
Format: Electronic Article Electronic Article
Language: English
Subjects:
Americas
Attitude of Health Personnel
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Cardiovascular risk
Cross-Sectional Studies
Dyslipidemia
Geography
Greece
Guideline Adherence - statistics & numerical data
Health Status Indicators
Humans
Lipid-lowering therapy
Netherlands
Physicians - statistics & numerical data
Portugal
Primary Health Care - statistics & numerical data
Primary prevention
Professional Practice - statistics & numerical data
Research Design - statistics & numerical data
Risk Factors
Surveys and Questionnaires
Quelle: Alma/SFX Local Collection
Publisher: England: Informa UK Ltd
ID: ISSN: 0300-7995
Link: https://www.ncbi.nlm.nih.gov/pubmed/19323611
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_informahealthcare_journals_10_1185_03007990902846423
title: Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions
format: Article
creator:
  • Sposito, Andrei C
  • Ramires, Jose A. F
  • Jukema, J. Wouter
  • Molina, Juan Carlos
  • Silva, Pedro Marques da
  • Ghadanfar, Mathieu M
  • Wilson, Peter W. F
subjects:
  • Americas
  • Attitude of Health Personnel
  • Cardiovascular Diseases - diagnosis
  • Cardiovascular Diseases - etiology
  • Cardiovascular Diseases - prevention & control
  • Cardiovascular risk
  • Cross-Sectional Studies
  • Dyslipidemia
  • Geography
  • Greece
  • Guideline Adherence - statistics & numerical data
  • Health Status Indicators
  • Humans
  • Lipid-lowering therapy
  • Netherlands
  • Physicians - statistics & numerical data
  • Portugal
  • Primary Health Care - statistics & numerical data
  • Primary prevention
  • Professional Practice - statistics & numerical data
  • Research Design - statistics & numerical data
  • Risk Factors
  • Surveys and Questionnaires
ispartof: Current medical research and opinion, 2009, Vol.25 (5), p.1171-1178
description: ABSTRACT Objective: To evaluate physicians' attitudes and adherence to the use of risk scores in the primary prevention of cardiovascular disease (CVD). Design and methods: A cross-sectional survey of 2056 physicians involved in the primary prevention of CVD. Participants included cardiologists (47%), general practitioners (42%), and endocrinologists (11%) from several geographical regions: Brazil (n = 968), USA (n = 381), Greece (n = 275), Chile (n = 157), Venezuela (n = 128), Portugal (n = 42), The Netherlands (n = 41), and Central America (Costa Rica, Panama, El Salvador and Guatemala; n = 64). Results: The main outcome measure was the percentage of responses on a multiple-choice questionnaire describing a hypothetical asymptomatic patient at intermediate risk for CVD according to the Framingham Risk Score. Only 48% of respondents reported regular use of CVD risk scores to tailor preventive treatment in the case scenario. Of non-users, nearly three-quarters indicated that 'It takes up too much of my time' (52%) or 'I don't believe they add value to the clinical evaluation' (21%). Only 56% of respondents indicated that they would prescribe lipid-lowering therapy for the hypothetical intermediate-risk patient. A significantly greater proportion of regular users than non-users of CVD risk scores identified the need for lipid-lowering therapy in the hypothetical patient (59 vs. 41%; p 
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0300-7995
fulltext: fulltext
issn:
  • 0300-7995
  • 1473-4877
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.3693454
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_cross
recordidTN_cdi_informahealthcare_journals_10_1185_03007990902846423
sourceformatXML
sourcesystemPC
ingidapl/cmro/2009/00000025/00000005/art00013
sourcerecordid67175850
originalsourceidFETCH-LOGICAL-1510t-e6aba0f85166c36d886b10cb206830882bcc995f36fed537bd5cf917921d0a53
addsrcrecordideNp9UcuO1DAQjBCIXRY-gAvyCU4BOx7nAXtZrXhJK8Fh71bH7ux4ceLB7QyaT-FvcWYGIUAaX8pSV5XdVUXxXPDXQrTqDZecN13HO161q3pVyQfFuVg1sly1TfOwOF_mZSaos-IJ0T3nomq77nFxJjpZyVqI8-Ln1_WOnHEw0SsGKbk0WyQGk2Vg1xhxMshSYDMhCwOLjr4xMiFmzhAi20Q3QtxlxC1OyYVpYRmI1oUtkJk9RGYdIRC-ZSYGopLQLETwjOa4xR1zE0vriMh-hOgti3iXx_S0eDSAJ3x2xIvi9sP72-tP5c2Xj5-vr25KoQRPJdbQAx9aJerayNq2bd0LbvqK163kbVv1xuQEBlkPaJVseqvM0Immq4TloORF8fJgu4nh-4yU9OjIoPcwYZhJ141oVKt4JooDcb9FxEEfl9eC66UO_V8dWfPiaD73I9o_imP-mdD8Y2pcgiWeFMH5k9ZXB6Wb7nLyoGkE7_M7pGHjtRlj0BXnneb7U6njhSsNMWUUi8flb49c5gj7_HWCnQ9xiDAZR1qe-sK7v-RrBJ_WuXzU92GOuWE6scAv2bbTng
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid67175850
display
typearticle
titlePhysicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions
sourceAlma/SFX Local Collection
creatorSposito, Andrei C ; Ramires, Jose A. F ; Jukema, J. Wouter ; Molina, Juan Carlos ; Silva, Pedro Marques da ; Ghadanfar, Mathieu M ; Wilson, Peter W. F
creatorcontribSposito, Andrei C ; Ramires, Jose A. F ; Jukema, J. Wouter ; Molina, Juan Carlos ; Silva, Pedro Marques da ; Ghadanfar, Mathieu M ; Wilson, Peter W. F
descriptionABSTRACT Objective: To evaluate physicians' attitudes and adherence to the use of risk scores in the primary prevention of cardiovascular disease (CVD). Design and methods: A cross-sectional survey of 2056 physicians involved in the primary prevention of CVD. Participants included cardiologists (47%), general practitioners (42%), and endocrinologists (11%) from several geographical regions: Brazil (n = 968), USA (n = 381), Greece (n = 275), Chile (n = 157), Venezuela (n = 128), Portugal (n = 42), The Netherlands (n = 41), and Central America (Costa Rica, Panama, El Salvador and Guatemala; n = 64). Results: The main outcome measure was the percentage of responses on a multiple-choice questionnaire describing a hypothetical asymptomatic patient at intermediate risk for CVD according to the Framingham Risk Score. Only 48% of respondents reported regular use of CVD risk scores to tailor preventive treatment in the case scenario. Of non-users, nearly three-quarters indicated that 'It takes up too much of my time' (52%) or 'I don't believe they add value to the clinical evaluation' (21%). Only 56% of respondents indicated that they would prescribe lipid-lowering therapy for the hypothetical intermediate-risk patient. A significantly greater proportion of regular users than non-users of CVD risk scores identified the need for lipid-lowering therapy in the hypothetical patient (59 vs. 41%; p < 0.0001). Conclusions: Based on a survey conducted in a 'real-world' setting, risk scores are generally not used by a majority of physicians to guide primary prevention in asymptomatic persons at intermediate risk for CVD. Appropriate prescribing of lipid-lowering therapy in such patients is equally neglected. Changing physicians' attitudes towards the use of CVD risk scores is one of several challenges that need to be addressed to reduce the world-wide burden of CVD.
identifier
0ISSN: 0300-7995
1EISSN: 1473-4877
2DOI: 10.1185/03007990902846423
3PMID: 19323611
languageeng
publisherEngland: Informa UK Ltd
subject
ispartofCurrent medical research and opinion, 2009, Vol.25 (5), p.1171-1178
rights2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009
lds50peer_reviewed
citedbyFETCH-LOGICAL-1510t-e6aba0f85166c36d886b10cb206830882bcc995f36fed537bd5cf917921d0a53
citesFETCH-LOGICAL-1510t-e6aba0f85166c36d886b10cb206830882bcc995f36fed537bd5cf917921d0a53
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19323611$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Sposito, Andrei C
1Ramires, Jose A. F
2Jukema, J. Wouter
3Molina, Juan Carlos
4Silva, Pedro Marques da
5Ghadanfar, Mathieu M
6Wilson, Peter W. F
title
0Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions
1Current medical research and opinion
addtitleCurr Med Res Opin
descriptionABSTRACT Objective: To evaluate physicians' attitudes and adherence to the use of risk scores in the primary prevention of cardiovascular disease (CVD). Design and methods: A cross-sectional survey of 2056 physicians involved in the primary prevention of CVD. Participants included cardiologists (47%), general practitioners (42%), and endocrinologists (11%) from several geographical regions: Brazil (n = 968), USA (n = 381), Greece (n = 275), Chile (n = 157), Venezuela (n = 128), Portugal (n = 42), The Netherlands (n = 41), and Central America (Costa Rica, Panama, El Salvador and Guatemala; n = 64). Results: The main outcome measure was the percentage of responses on a multiple-choice questionnaire describing a hypothetical asymptomatic patient at intermediate risk for CVD according to the Framingham Risk Score. Only 48% of respondents reported regular use of CVD risk scores to tailor preventive treatment in the case scenario. Of non-users, nearly three-quarters indicated that 'It takes up too much of my time' (52%) or 'I don't believe they add value to the clinical evaluation' (21%). Only 56% of respondents indicated that they would prescribe lipid-lowering therapy for the hypothetical intermediate-risk patient. A significantly greater proportion of regular users than non-users of CVD risk scores identified the need for lipid-lowering therapy in the hypothetical patient (59 vs. 41%; p < 0.0001). Conclusions: Based on a survey conducted in a 'real-world' setting, risk scores are generally not used by a majority of physicians to guide primary prevention in asymptomatic persons at intermediate risk for CVD. Appropriate prescribing of lipid-lowering therapy in such patients is equally neglected. Changing physicians' attitudes towards the use of CVD risk scores is one of several challenges that need to be addressed to reduce the world-wide burden of CVD.
subject
0Americas
1Attitude of Health Personnel
2Cardiovascular Diseases - diagnosis
3Cardiovascular Diseases - etiology
4Cardiovascular Diseases - prevention & control
5Cardiovascular risk
6Cross-Sectional Studies
7Dyslipidemia
8Geography
9Greece
10Guideline Adherence - statistics & numerical data
11Health Status Indicators
12Humans
13Lipid-lowering therapy
14Netherlands
15Physicians - statistics & numerical data
16Portugal
17Primary Health Care - statistics & numerical data
18Primary prevention
19Professional Practice - statistics & numerical data
20Research Design - statistics & numerical data
21Risk Factors
22Surveys and Questionnaires
issn
00300-7995
11473-4877
fulltexttrue
rsrctypearticle
creationdate2009
recordtypearticle
recordideNp9UcuO1DAQjBCIXRY-gAvyCU4BOx7nAXtZrXhJK8Fh71bH7ux4ceLB7QyaT-FvcWYGIUAaX8pSV5XdVUXxXPDXQrTqDZecN13HO161q3pVyQfFuVg1sly1TfOwOF_mZSaos-IJ0T3nomq77nFxJjpZyVqI8-Ln1_WOnHEw0SsGKbk0WyQGk2Vg1xhxMshSYDMhCwOLjr4xMiFmzhAi20Q3QtxlxC1OyYVpYRmI1oUtkJk9RGYdIRC-ZSYGopLQLETwjOa4xR1zE0vriMh-hOgti3iXx_S0eDSAJ3x2xIvi9sP72-tP5c2Xj5-vr25KoQRPJdbQAx9aJerayNq2bd0LbvqK163kbVv1xuQEBlkPaJVseqvM0Immq4TloORF8fJgu4nh-4yU9OjIoPcwYZhJ141oVKt4JooDcb9FxEEfl9eC66UO_V8dWfPiaD73I9o_imP-mdD8Y2pcgiWeFMH5k9ZXB6Wb7nLyoGkE7_M7pGHjtRlj0BXnneb7U6njhSsNMWUUi8flb49c5gj7_HWCnQ9xiDAZR1qe-sK7v-RrBJ_WuXzU92GOuWE6scAv2bbTng
startdate200905
enddate200905
creator
0Sposito, Andrei C
1Ramires, Jose A. F
2Jukema, J. Wouter
3Molina, Juan Carlos
4Silva, Pedro Marques da
5Ghadanfar, Mathieu M
6Wilson, Peter W. F
general
0Informa UK Ltd
1Taylor & Francis
2Informa Healthcare
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
87X8
sort
creationdate200905
titlePhysicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions
authorSposito, Andrei C ; Ramires, Jose A. F ; Jukema, J. Wouter ; Molina, Juan Carlos ; Silva, Pedro Marques da ; Ghadanfar, Mathieu M ; Wilson, Peter W. F
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1510t-e6aba0f85166c36d886b10cb206830882bcc995f36fed537bd5cf917921d0a53
rsrctypearticles
prefilterarticles
languageeng
creationdate2009
topic
0Americas
1Attitude of Health Personnel
2Cardiovascular Diseases - diagnosis
3Cardiovascular Diseases - etiology
4Cardiovascular Diseases - prevention & control
5Cardiovascular risk
6Cross-Sectional Studies
7Dyslipidemia
8Geography
9Greece
10Guideline Adherence - statistics & numerical data
11Health Status Indicators
12Humans
13Lipid-lowering therapy
14Netherlands
15Physicians - statistics & numerical data
16Portugal
17Primary Health Care - statistics & numerical data
18Primary prevention
19Professional Practice - statistics & numerical data
20Research Design - statistics & numerical data
21Risk Factors
22Surveys and Questionnaires
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Sposito, Andrei C
1Ramires, Jose A. F
2Jukema, J. Wouter
3Molina, Juan Carlos
4Silva, Pedro Marques da
5Ghadanfar, Mathieu M
6Wilson, Peter W. F
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7MEDLINE - Academic
jtitleCurrent medical research and opinion
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Sposito, Andrei C
1Ramires, Jose A. F
2Jukema, J. Wouter
3Molina, Juan Carlos
4Silva, Pedro Marques da
5Ghadanfar, Mathieu M
6Wilson, Peter W. F
formatjournal
genrearticle
ristypeJOUR
atitlePhysicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions
jtitleCurrent medical research and opinion
addtitleCurr Med Res Opin
date2009-05
risdate2009
volume25
issue5
spage1171
epage1178
pages1171-1178
issn0300-7995
eissn1473-4877
abstractABSTRACT Objective: To evaluate physicians' attitudes and adherence to the use of risk scores in the primary prevention of cardiovascular disease (CVD). Design and methods: A cross-sectional survey of 2056 physicians involved in the primary prevention of CVD. Participants included cardiologists (47%), general practitioners (42%), and endocrinologists (11%) from several geographical regions: Brazil (n = 968), USA (n = 381), Greece (n = 275), Chile (n = 157), Venezuela (n = 128), Portugal (n = 42), The Netherlands (n = 41), and Central America (Costa Rica, Panama, El Salvador and Guatemala; n = 64). Results: The main outcome measure was the percentage of responses on a multiple-choice questionnaire describing a hypothetical asymptomatic patient at intermediate risk for CVD according to the Framingham Risk Score. Only 48% of respondents reported regular use of CVD risk scores to tailor preventive treatment in the case scenario. Of non-users, nearly three-quarters indicated that 'It takes up too much of my time' (52%) or 'I don't believe they add value to the clinical evaluation' (21%). Only 56% of respondents indicated that they would prescribe lipid-lowering therapy for the hypothetical intermediate-risk patient. A significantly greater proportion of regular users than non-users of CVD risk scores identified the need for lipid-lowering therapy in the hypothetical patient (59 vs. 41%; p < 0.0001). Conclusions: Based on a survey conducted in a 'real-world' setting, risk scores are generally not used by a majority of physicians to guide primary prevention in asymptomatic persons at intermediate risk for CVD. Appropriate prescribing of lipid-lowering therapy in such patients is equally neglected. Changing physicians' attitudes towards the use of CVD risk scores is one of several challenges that need to be addressed to reduce the world-wide burden of CVD.
copEngland
pubInforma UK Ltd
pmid19323611
doi10.1185/03007990902846423